Meticulous Research®, a globally recognized market research firm, has published its latest report titled “ELISA Market Size, Share, Forecast & Trends Analysis by Type (Direct, Sandwich, Competitive), Offering (Analyzer, Software), Technology (Chemiluminescence, Colorimetry, Fluorescence), Application (Research, Diagnostic), End User—Global Forecast to 2031.” According to the report, the global ELISA market is expected to grow at a CAGR of 6.1%, reaching $32.69 billion by 2031.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5997?
The expansion of the ELISA market is driven by the increasing prevalence of chronic and infectious diseases, advancements in ELISA technology, and its growing applications in clinical and food industries. Despite these opportunities, challenges like the high costs of ELISA antibody preparation and the risk of false positives pose potential hurdles.
Opportunities and Challenges
Emerging markets, increased R&D in biomarker detection, and a growing emphasis on vaccine development offer promising growth avenues. However, stringent regulatory frameworks and the availability of alternative diagnostic technologies remain significant challenges.
